Vnitr Lek 2022, 68(6):E23-E27 | DOI: 10.36290/vnl.2022.087

New onset of diabetes mellitus and weight loss as a manifestation of pancreatic cancer

Aleš Dvořák, Miroslav Souček
II. interní klinika, Fakultní nemocnice u sv. Anny v Brně

The case report is about a 68-years-old man who developed a weight loss and diabetes mellitus as early symptoms of pancreatic cancer several months before the diagnosis. Unfortunately, the diagnosis was made too late, at the stage of generalized disease, when symptomatic treatment was the only possible way. The aim of the article is to warn about this possible way of pancreatic cancer manifestation, because only the diagnosis determined in time, when the tumor is localized, allows its resection - the only curative treatment method. For this reason, it is necessary to consider the presence of pancreatic cancer in the case of an atypical manifestation of diabetes.

Keywords: diabetes mellitus, weight loss, pancreatic cancer.

Accepted: September 23, 2022; Published: October 3, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dvořák A, Souček M. New onset of diabetes mellitus and weight loss as a manifestation of pancreatic cancer. Vnitr Lek. 2022;68(6):E23-27. doi: 10.36290/vnl.2022.087.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Češka R et al. Interna 3. vydání. Praha/Kroměříž: Triton 2020, 964 stran. ISBN 978-80-7553-782-9
    2. Frič P, Šedo A, Škrha J et al. Early detection of sporadic pancreatic cancer: time for change. Eur J Gastroenterol Hepatol. 2017 Aug;29(8):885-891. Go to original source... Go to PubMed...
    3. Škrha J., Frič P., Bušek P. et al., Sporadic Pancreatic Cancer: Glucose Homeostasis and Pancreatogenic Type 3 Diabetes, in Advances in Pancreatic Cancer. London, United Kingdom: IntechOpen, 2018 Go to original source...
    4. Škrha P., Diabetes mellitus a karcinom pankreatu - příčina nebo následek? Vnitř Lék 2014; 60(9): 787-790. Go to PubMed...
    5. Dušek L, Mužík J, Kubásek M et at. Epidemiologie zhoubných nádorů v České republice. [cit. 2022-6-10]. Dostupný z WWW: http://www.svod.cz.
    6. McGuigan A, Kelly P, Turkington RC et al. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018 Nov 21;24(43):4846-4861. Go to original source... Go to PubMed...
    7. Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018 May 21;24(19)2047-2060. Go to original source... Go to PubMed...
    8. Mueller AM, Meier CR, Jick SS et al. Characterization of the deterioration of diabetes control in patients with a subsequent diagnosis of pancreatic cancer: A descriptive study. Pancreatology. 2022 Apr;22(3):387-395. Go to original source... Go to PubMed...
    9. Loveday BPT, Lipton L, Thomson BN. Pancreatic cancer: An update on diagnosis and management. Aust J Gen Pract. 2019 Dec;48(12):826-831. Go to original source... Go to PubMed...
    10. Tempero MA. NCCN Guidelines Updates: Pancreatic Cancer. J Natl Compr Canc Netw. 2019 May 1;17(5.5):603-605. Go to original source... Go to PubMed...
    11. Torphy RJ, Fujiwara Y, Schulick RD. Pancreatic cancer treatment: better, but a long way to go. Surg Today. 2020 Oct;50(10):1117-1125. Go to original source... Go to PubMed...
    12. Zhu H, Wei M, Xu J et al. PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications. Mol Cancer. 2020 Mar 2;19(1):49. Go to original source... Go to PubMed...
    13. Morrison AH, Byrne KT, Vonderheide RH. Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer. 2018 Jun;4(6):418-428. Go to original source... Go to PubMed...
    14. Ren B, Cui M, Yang G et al. Tumor microenvironment participates in metastasis of pancreatic cancer. Mol Cancer. 2018 Jul 30;17(1):108. Go to original source... Go to PubMed...
    15. Sharma A, Kandlakunta H, Nagpal SJS et al. Model to Determine Risk of Pancreatic Cancer in Patients With New‑Onset Diabetes. Gastroenterology. 2018 Sep;155(3):730-739. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.